Helping families navigate a "post pandemic" world
Contemporary Pediatrics spoke with Andrew J. Schuman, MD, FAAP, about how to help families with mixed COVID-19 vaccine status remain safe and healthy.
With COVID-19 vaccines available to everyone 12 years of age and older, life in the United States is starting to return to its familiar rhythms, but some families may be left wondering how to keep everyone in the family safe when only some can be vaccinated,
Contemporary Pediatrics spoke with Andrew J. Schuman, MD, FAAP, about how to help those families remain safe and healthy.
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
